Top Markets
#1 TENDIES TENDIES +31.93%
#2 Cash Cat Cash Cat +17.71%
#3 OSK OSK +15.33%
#4 Seeker Seeker +8.17%
#5 Tornado Cash Tornado Cash +6.73%
#6 Big Time Big Time +6.31%
#7 Nesa Nesa +6.00%
#8 UnifAI Network UnifAI Network +5.06%
#9 Staked ZIG Staked ZIG +4.30%
#10 Jelly-My-Jelly Jelly-My-Jelly +4.11%
Coin of the day
TENDIES TENDIES
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Classificação em ações #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Preço da ação
$3.78
Última sincronização: 2026-03-17
Valor de mercado
$276.54M
Variação (1 dia)
0.00%
Variação (1 ano)
45.53%
País
CA
Negociar NervGen Pharma Corp. (NGEN)

Categoria

Healthcare
Lucros da NervGen Pharma Corp. (NGEN)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da NervGen Pharma Corp., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da NervGen Pharma Corp. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH